Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How can academic researchers more effectively contribute to environmental toxicology and health efforts for regulatory decisions, policymakers, nonprofits, and communities?

Journal of toxicology and environmental health. Part B, Critical reviews·2026
Same author

European Food Safety Authority database for <i>in vivo</i> developmental neurotoxicity studies of pesticides.

Critical reviews in toxicology·2025
Same author

Developmental neurotoxicity (DNT): A call for implementation of new approach methodologies for regulatory purposes: Summary of the 5th International Conference on DNT Testing.

ALTEX·2025
Same author

A developmental neurotoxicity adverse outcome pathway (DNT-AOP) with voltage gate sodium channel (VGSC) inhibition as a molecular initiating event (MiE).

EFSA journal. European Food Safety Authority·2024
Same author

Establishment of a human cell-based in vitro battery to assess developmental neurotoxicity hazard of chemicals.

Chemosphere·2022
Same author

Current status and future directions for a neurotoxicity hazard assessment framework that integrates <i>in silico</i> approaches.

Computational toxicology (Amsterdam, Netherlands)·2022

Related Experiment Video

Updated: May 19, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation.

Ryozo Tsuji1, Kevin M Crofton

  • 1Environmental Health Science Laboratory, Sumitomo Chemical Co. Ltd, Osaka, Japan. tsujir@sc.sumitomo-chem.co.jp

Congenital Anomalies
|August 29, 2012
PubMed
Summary

Developmental neurotoxicity (DNT) testing guidelines face challenges in methodology, evaluation, and regulation, impacting children's health assessments. Addressing these issues is crucial for reliable chemical safety decisions and protecting developing nervous systems.

More Related Videos

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

Related Experiment Videos

Last Updated: May 19, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

Area of Science:

  • Environmental Health
  • Toxicology
  • Neuroscience

Background:

  • Growing concerns exist regarding environmental factors affecting children's nervous system development.
  • The U.S. Environmental Protection Agency (EPA) and Organisation for Economic Co-operation and Development (OECD) have established testing guidelines for developmental neurotoxicity (DNT).
  • Over 110 DNT guideline studies have been completed, providing data for chemical regulatory decisions.

Purpose of the Study:

  • To review uncertainties and challenges associated with current DNT testing guidelines.
  • To summarize discussions from a symposium focused on advancing DNT testing methodologies.
  • To identify areas for improvement in protecting children's developing nervous systems from environmental toxins.

Main Methods:

  • Review of existing DNT testing guidelines from EPA and OECD.
  • Analysis of methodological, evaluative, and regulatory uncertainties.
  • Summary of expert discussions from the 2011 Japanese Teratology Society meeting.

Main Results:

  • Identified methodological issues: incomplete harmonization, learning/memory test criticisms, and unspecified positive controls.
  • Highlighted evaluation challenges: morphometric artifacts, observation criteria, postnatal exposure uncertainty, and interspecies extrapolation.
  • Noted regulatory concerns: uncertainty in safety factors for infants/children, high costs, animal usage, and limited laboratory capacity.

Conclusions:

  • Current DNT guidelines present significant uncertainties and limitations.
  • There is a need for scientific approaches to develop next-generation DNT testing.
  • Improvements are essential for more accurate risk assessment and protection of children's neurodevelopment.